ClinPharmPod

Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes....

Clinical Pharmacology & Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT’s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field […]

Clinical Pharmacology & Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, “Getting the Dosage Right.” Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into […]

Clinical Pharmacology & Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If […]

Clinical Pharmacology & Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that […]

Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as […]

Clinical Pharmacology & Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover. If you’re interested in submitting your research [&#8230...

Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmaco...

Clinical Pharmacology & Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host […]

Clinical Pharmacology & Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave […]

Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a […]

ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias. You can access CPT’s […]

Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, an...

In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for […]

Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology & Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers. […]

For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 […]

On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected [&#823...

On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and...

In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under [&#8230...

In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer...

This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here. Listen and subscribe for free on iTunes and Google Play

This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here. Listen and subscribe for free on iTunes and Google Play

This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here. Listen and subscribe for free on iTunes and Google Play

This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here. Listen and subscribe for free on iTunes and Google Play

This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary “Microdosing Studies in Children: A US Regulatory Perspective” which published in the September 2016 issue of CPT. Read the commentary here. Listen and subscribe for free on iTunes and Google Play